ARL5C

mutation — cross-omics
Cross-omicsMUTATION → RNAPatientPairwise association · TCGA cohorts

Across TCGA patient cohorts, ARL5C mutation is significantly associated with the RNA expression of many other genes, with 88 significant associations in total. ESCA shows the largest number of these associations.

The most reproducible ARL5C-associated genes across cancer lineages are OR5I1, PRAMEF28P, and RNU6-1138P. Each is linked with ARL5C in more than 1 cancer types. Because this analysis shows association rather than direction, both ARL5C-to-partner and partner-to-ARL5C results are reported.

Each partner links to its own Q-omics profile. The box plot shows the strongest example, OR5I1 grouped by ARL5C-low versus ARL5C-high in ESCA.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ARL5C→partner) and Y-score (partner→ARL5C) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.
LineagePartner geneX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
ESCAOR5I1 →+0.222+5.450<.001.00432
UCECPRAMEF28P →+0.079+4.136.002.00131
COADRNU6-1138P →+0.463+5.790<.001.00331
COADCNN2P2 →+0.070+6.122<.001.00231
COADLINC00229 →+0.690+5.283<.001.00631
COADRPS14P7 →+0.206+5.602.003.00431
Each partner links to its Q-omics profile. Showing the 6 strongest of 88 associations by consensus.

OR5I1 by ARL5C expression — ESCA

Box plot of OR5I1 in ARL5C-low vs ARL5C-high samples in ESCA.

Explore this box plot interactively →

Exploration